Golden Helix Newsletter

Is Illumina Aiming to Compete with its Customers?
by Christophe Lambert, Chairman and CEO

Is Illumina Aiming to Compete with its Customers?
In a recent GenomeWeb article by Tony Fong, "Sequenom's CEO 'Puzzled' by Illumina's Buy of Verinata, Lays out 2013 Goals at JP Morgan," Harry Hixson, Sequenom's CEO, expresses puzzlement over why its major supplier, Illumina, is acquiring a Sequenom competitor in Non-Invasive Prenatal Testing (NIPT), and thus apparently competing with one of its major customers.

In a JP Morgan interview on January 8, 2013, Illumina CEO Jay Flatley said: "In terms of our market strategy in NIPT: we plan to leverage the Verify test to drive new applications while continuing to supply instruments and reagents to all the NIPT players. In fact, we are working very hard to reinforce our relationships with our existing customers in this field. We plan to partner to help with distribution of the Verify test, and we intend to outlicense the foundational IP broadly and hopefully through that method expand the market more quickly and resolve some of the underlying uncertainty in this marketplace." Continue reading »

X-GEN SHORT COURSE: Knowing Your Upstream: Comparison of Alignment and Variant Callers Used in Production Pipelines and their Limitations
Presenter: Gabe Rudy, VP of Product Development
Date: March 19, 2013 | Location: San Diego, CA


This presentation will compare the performance of the alignment and variant calling tools used by sequencing service providers including Illumina Genome Network, Complete Genomics and The Broad Institute. Using public samples analyzed by each pipeline, we will look at the level of concordance and dive into investigating problematic variants and regions of the genome.
Podcast Interview » | About Short Course » | Register for X-Gen »

New Plant and Animal Genomes and Tracks Now Available!
by Greta Linse Peterson, Product Quality Manager/Senior Statistician
New plant and animal genomes

We're pleased to announce the addition of genome maps and annotation tracks for two new plant species and added new versions of genome maps and annotation tracks for the cow and pig genomes. These new Reference Sequence and Gene tracks are available for use in both SVS 7 and GenomeBrowse. Continue reading »
   Upcoming Webcast
Insights: Identification of Candidate Variants using Exome Data in Ophthalmic Genetics

Khanh-Nhat Tran-Viet, MHA, Manager/Research Analyst II, Duke University

  Thurs, March 7
12:00 pm EST

Webcast Registration

   New SVS Scripts
Three new scripts and two updated ones
More info » | Script repository »

PLoS ONE Publishes Results of Autism Study
Director of Services, Dr. Bryce Christensen, and CEO, Dr. Christophe Lambert, are authors on the paper.
Continue reading »

Where will we see you next?
X-GEN Congress & Expo
San Diego, CA  |  Mar 18-20

TCGC Annual Clinical Genome Conference
San Francisco, CA  |  Jun 25-28

Facebook     Twitter     Linked In     Blog   YouTube

Recent Customer Success Highlights

Nature Genetics
Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1
Kirino, Y et al.
US National Institutes of Health
Read the article »

Identification of Rare Recurrent Copy Number Variants in High-Risk Autism Families and Their Prevalence in a Large ASD Population
Matsunami, N et al.
University of Utah
Read the article »

Genes and Immunity
Allelic mRNA expression imbalance in C-type lectins reveals a frequent regulatory SNP in the human surfactant protein A (SP-A) gene
Azad, A et al.
The Ohio State
Read the article »

BCL9 and C9orf5 Are Associated with Negative Symptoms in Schizophrenia: Meta-Analysis of Two Genome-Wide Association Studies
Xu, C et al.
Texas Tech
Read the article »

Inflammation and Immune-Related Candidate Gene Associations with Acute Lung Injury Susceptibility and Severity: A Validation Study
O'Mahony, S et al.
University of Washington
Read the article »

Kidney International
A family-based association study after genome-wide linkage analysis identified two genetic loci for renal function in a Mongolian population
Park, H et al.
Seoul National University
Read the article »

About Golden Helix
Founded in 1998, Golden Helix is known for helping genetic research groups working with large-scale DNA-sequencing or microarray data overcome the frustration and challenges of bioinformatic roadblocks: delayed projects, lack of quality findings, and low productivity. By empowering researchers with highly effective software tools, world-class support, and an array of complementary analytic services, we refute the notion that analysis has to be difficult or time consuming. Golden Helix's flagship software product, SNP & Variation Suite (SVS), is an integrated collection of powerful data management, quality assurance, visualization, and tertiary analysis tools for genetic data. SVS is delivered in a user-friendly, scalable platform and is supported by a team of highly trained bioinformaticians, statistical geneticists, and computer scientists that together make advanced statistical and bioinformatic methods accessible to scientists of all levels.


Copyright 2000-2013 Golden Helix, Inc. All Rights Reserved.
Golden Helix, Inc. | 203 Enterprise, Blvd. | Bozeman, MT | 59718